Publications

Neoadjuvant Durvalumab in Non-Surgical Early Stage/Locally Advanced Non-Small Cell Lung Cancer (Nsclc) Followed by Radical Rt/Crt (Idear) Study Concept of a Phase Ii Investigator Initiated Clinical Trial

AuthID
P-00X-KSV

Author(s)

Gaspar, CF

Oliveira, J

Document Type

Abstract

Year published

2022

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 33, Issue: 7, Pages: S981-S981 (1)

Conference

Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: SEP 09-13, 2022, Location: ELECTR NETWORK, Sponsors: European Soc Med Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.annonc.2022.07.1074

Wos: WOS:000866211601217

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Neoadjuvant Durvalumab in Non-Surgical Early Stage/Locally Advanced Non-Small Cell Lung Cancer (Nsclc) Followed by Radical Rt/Crt (Idear) Study Concept of a Phase Ii Investigator Initiated Clinical Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Neoadjuvant Durvalumab in Non-Surgical Early Stage/Locally Advanced Non-Small Cell Lung Cancer (Nsclc) Followed by Radical Rt/Crt (Idear) Study Concept of a Phase Ii Investigator Initiated Clinical Trial

Useful Links

Get Help